KY
KYNTRA BIO INC
KYNB·31572Q881·US·Common Stock·Healthcare - Biotechnology-13D/G
KYNB (KYNTRA BIO INC) is held by 18 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.2M), BlackRock, Inc. ($636,692), GEODE CAPITAL MANAGEMENT, LLC ($326,385). Net institutional sentiment: Bearish.
18
Holders
(1 Elite)
$3.4M
Total Value
31% (16)
Consensus
5 buying - 11 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 28, 2026 · Insiders May 19, 2026 · Activists Aug 14, 2026 · Congress none
ActivistARArmistice Capital, LLC9.9%Aug 14, 2026
ActivistARArmistice Capital, LLC9.9%May 15, 2026
InsiderWTWettig ThaneBuy $20KMay 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 21
1 / 2
KYKYNBKYNTRA BIO INC
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer